Abstract
To determine whether universal infant immunization affects occult hepatitis B virus (HBV) infection (OBI), serum samples from hepatitis B surface antigen (HBsAg)‐negative subjects P = 0.007), tended to be higher in vaccinated than unvaccinated anti‐HBc‐positive subjects (16 of 334 [4.8%] vs. 3 of 181 [1.7%]; P = 0.072), and was higher in vaccinated than unvaccinated subjects seropositive for both antibody to hepatitis B surface antigen (anti‐HBs) and anti‐HBc (13 of 233 [5.6%] vs. 3 of 170 [1.8%]; P = 0.025). By using known anti‐HBc seropositivity rate in children in our serosurveys, the estimated OBI frequency per 104 HBsAg‐negative subjects declined from 160.7 in unvaccinated cohorts to 11.5 in vaccinated cohorts. In vaccinated cohorts, OBI frequency was higher in anti‐HBc‐positive subjects than in anti‐HBc‐negative subjects (16 of 334 [4.8%] vs. 0 of 392 [0%]; P < 0.001). Subjects with OBI had much lower viral load (P < 0.001) and a trend of higher mutation rates in “a” determinant of HBsAg than age‐comparable, HBsAg‐positive subjects. Conclusions: Reduction of OBI in immunized subjects complements the well‐documented universal infant immunization‐related benefit of markedly reduced overt HBV infection. Breakthrough infections in immunized subjects seem to associate with more occurrence of OBI than natural infections in unvaccinated subjects. In the postvaccination era, anti‐HBc seropositivity is a useful marker for OBI screening in HBsAg‐negative subjects, and a very‐low‐level viral replication and HBsAg expression is the major mechanism underlying OBI. (Hepatology 2015;61:1183–1191)

This publication has 26 references indexed in Scilit: